Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

MXene Bioinks for 3D Bioprinting: Design and Translation.

Created on 28 Jul 2026

Authors

Begüm Sarac, Seydanur Yücer, Fatih Ciftci

Published in

Small (Weinheim an der Bergstrasse, Germany). Pages e74819. Jul 28, 2026. Epub Jul 28, 2026.

Abstract

MXenes have emerged as electrically conductive, hydrophilic two-dimensional nanomaterials uniquely suited for electroactive bioink development. However, the field lacks an integrated design framework that links MXene surface chemistry and colloidal behavior to printability, electrical percolation, and tissue-specific biological outcomes. This review establishes a structure rheology biofunction paradigm for MXene-based bioinks, critically examining how synthesis routes, surface terminations, and oxidation dynamics influence shear-thinning behavior, network formation, and cytocompatibility. We analyze mechanistic pathways underlying cell-material interactions, including electrically mediated signaling and mechanotransduction in three-dimensional constructs. Emerging in vivo studies are evaluated with emphasis on biodistribution, immune modulation, and long-term biodegradation. Finally, we define key translational bottlenecks, oxidative instability, reproducibility, sterilization sensitivity, and regulatory classification, and propose actionable design criteria to advance MXene bioinks from laboratory constructs to clinically viable electroactive scaffolds.

PMID:
42517678
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement